Company Monitoring Page for Regeneron

job ratings for Regeneron

12/30/22
industry:
Big Pharma
company:
Regeneron
job rating:
1
My boss is abusive
10/21/17
industry:
Bio-Tech
job title:
Medical Specialist Immunology
company:
Regeneron
job rating:
7
Best company I’ve ever worked for. Best DM, best upper management, focus strongly on older, successful reps.
06/06/17
industry:
Bio pharmaceutical Industry
company:
Regeneron
job rating:
5
I have lived my job until lately. We are being forced to become Moreno like Sanofi. I now want to leave my job and go elsewhere because of it.
05/29/17
industry:
pharma
company:
Regeneron
job rating:
1
culture
01/29/17
industry:
Biotechnology
company:
Regeneron
job rating:
7
Transparency is great! pay is decent. Bonus opportunity is good.

latest headlines for company on cafepharma

Regeneron anticoagulant bests enoxaparin, matches Eliquis in phase 2 trial
Fierce Biotech
Thu, 12/19/24 - 11:31 am
Tags:
Regeneron, REGN7508, anticoagulants, enoxaparin, Eliquis, clinical trials
Regeneron, Bayer Build Retinal Vein Occlusion Case for Eylea as Biosimilar Pressure Mounts
BioSpace
Wed, 12/18/24 - 11:12 am
Tags:
Regeneron, Bayer, retinal vein occlusion, Eyelea
Regeneron’s R&D approach scores dual wins against Alexion’s Ultomiris and in lymphoma
Pharma Voice
Thu, 12/12/24 - 11:33 am
Tags:
ASH 2024, Regeneron, lymphoma, Alexion, Ultomiris
FDA To Revisit Regeneron/Sanofi's Dupixent For Rare Skin Disease
Benzinga
Fri, 11/15/24 - 11:15 am
Tags:
Regeneron, Sanofi, Dupixent, FDA, chronic spontaneous urticaria
Regeneron Reports Mixed Q3 Sales as Eylea Franchise Remains Under Pressure
BioSpace
Fri, 11/1/24 - 10:54 am
Tags:
Regeneron, Eylea, earnings
Regeneron loses bid to block Amgen's Eylea biosimilar launch in US
Reuters
Tue, 10/22/24 - 11:30 pm
Tags:
Regeneron, Amgen, biosimilars, Eylea
Regeneron takes the long-haul approach to oncology, stumbles and all
Pharma Voice
Thu, 10/10/24 - 09:52 am
Tags:
Regeneron, cancer, oncology, Libtayo
FDA, after delay, clears Regeneron and Sanofi drug for COPD
BioPharma Dive
Mon, 09/30/24 - 09:25 am
Tags:
Regeneron, Sanofi, Dupixent, COPD, FDA
Sanofi's Dupixent scores double COPD win in US, China
Pharmaphorum
Mon, 09/30/24 - 09:16 am
Tags:
Sanofi, Regeneron, Dupixent, COPD, China
Regeneron's stock drops as it loses bid to block Amgen's Eylea biosimilar
Fierce Pharma
Tue, 09/24/24 - 11:56 am
Tags:
Regeneron, Amgen, legal, biosimilars, Eylea
ESMO 2024: Regeneron’s melanoma combo therapy benefit continues beyond two years
Clinical Trials Arena
Mon, 09/16/24 - 09:46 am
Tags:
ESMO, Regeneron, melanoma, clinical trials, fiablimab
Radiant Bio closes $35 million Series A funding for antibody platform
Citybiz
Wed, 09/11/24 - 11:48 am
Tags:
Radiant Bio, funding, GSK, Regeneron, antibody platform
3 FDA approval dates to watch in the year’s final push
Pharma Voice
Wed, 09/11/24 - 11:39 am
Tags:
FDA, Bristol Myers Squibb, KarXT, schizophrenia, Regeneron, Sanofi, Dupixent, COPD, BridgeBio, acoramidis, ATTR cardiomyopathy
Dupixent succeeds in chronic hives study, giving Sanofi, Regeneron a chance to rebound
BioPharma Dive
Wed, 09/11/24 - 11:19 am
Tags:
Dupixent, chronic hives, Sanofi, Regeneron, FDA
Regeneron joins Koneksa Parkinson's digital biomarker study
Pharmaphorum
Wed, 09/4/24 - 11:22 am
Tags:
Regeneron, Koneska Health, digital biomarkers, Parkinson's Disease, Merck
After FDA rejection, Regeneron gains nod in Europe for T-cell engager odronextamab
Fierce Pharma
Mon, 08/26/24 - 11:20 am
Tags:
Regeneron, Europe, FDA, Ordspono, bispecifics, T-cell engager
FDA declines to approve Regeneron's blood cancer therapy
Reuters
Tue, 08/20/24 - 09:59 pm
Tags:
Regeneron, FDA, linvoseltamab, Multiple Myeloma
BioNTech, Regeneron’s mRNA Cancer Vaccine Combo Clears Phase II in Melanoma
BioSpace
Tue, 07/30/24 - 11:41 am
Tags:
BioNTech, Regeneron, Merck, Moderna Therapeutics, mRNA-4157/V940, melanoma
7 years after launch, Sanofi’s Dupixent is set for a megablockbuster run
Pharma Voice
Tue, 07/30/24 - 11:30 am
Tags:
Sanofi, Regeneron, Dupixent
Trials to watch: Four biologics concluding pivotal COPD trials
Clinical Trials Arena
Thu, 07/25/24 - 11:36 am
Tags:
COPD, biologics, clinical trials, GSK, Nucala, AstraZeneca, Fasenra, Roche, astegolimab, Sanofi, Regeneron, Dupixent

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.